title: Successful treatment by paroxetine of delusional disorder, somatic type, accompanied by severe secondary depression.
abstract: The case of a 42-year-old woman with delusional disorder, somatic type (DDST), with infestation delusion and delusions of body odor and halitosis accompanied by severe secondary depression is presented. These somatic delusions and depressive symptoms responded favorably to treatment with paroxetine 10 to 30 mg/d. Hypoperfusion in the left temporal and parietal lobes observed when she had marked clinical symptoms was improved at near recovery. The present report suggests that paroxetine is effective and a reasonable drug for DDST with secondary depression. It also supports previous observations that DDST is associated with hypoperfusion in the temporal and parietal lobes.
authors.affiliation: From the Department of Psychiatry, Yamagata University School of Medicine, Yamagata, Japan. hhayashi@med.id.yamagata-u.ac.jp
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Hayashi
authors.forename: Takaki
authors.initials: T
authors.lastname: Akahane
authors.forename: Haruyoshi
authors.initials: H
authors.lastname: Suzuki
authors.forename: Tetsuya
authors.initials: T
authors.lastname: Sasaki
authors.forename: Shinobu
authors.initials: S
authors.lastname: Kawakatsu
authors.forename: Koichi
authors.initials: K
authors.lastname: Otani
mesh_terms: D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000494:pharmacology / Q000627:therapeutic use*; D003863:Depression / Q000150:complications* / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D010296:Parietal Lobe / Q000187:drug effects; D017374:Paroxetine / Q000494:pharmacology / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D012563:Schizophrenia, Paranoid / Q000150:complications* / Q000188:drug therapy* / Q000473:pathology; D012720:Severity of Illness Index; D013702:Temporal Lobe / Q000187:drug effects
chemical_list: D018687:Antidepressive Agents, Second-Generation; D017374:Paroxetine